X-8465946-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001001888.4(VCX3B):c.304G>A(p.Asp102Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., 0 hem., cov: 13)
Exomes 𝑓: 0.000029 ( 0 hom. 3 hem. )
Failed GnomAD Quality Control
Consequence
VCX3B
NM_001001888.4 missense
NM_001001888.4 missense
Scores
1
15
Clinical Significance
Conservation
PhyloP100: -0.174
Genes affected
VCX3B (HGNC:31838): (variable charge X-linked 3B) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes, and all are expressed exclusively in male germ cells. The X-linked members are clustered on chromosome Xp22, and the Y-linked members are two identical copies of the gene within a palindromic region on chromosome Yq11. The family members share a high degree of sequence identity, with the exception that a 30-nt unit is tandemly repeated in X-linked members but occurs only once in Y-linked members. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This family member, as represented by the reference genome allele, contains 14 copies of the 30-nt repeat unit. VCX/Y genes encode small and highly charged proteins containing putative bipartite nuclear localization signals. Although the exact function of this family member has yet to be determined, a role in mRNA stability regulation can be inferred from the ability of the highly similar family member, VCX-A, to inhibit mRNA decapping. A possible role in the regulation of ribosome assembly during spermatogenesis has also been suggested. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008478224).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCX3B | NM_001001888.4 | c.304G>A | p.Asp102Asn | missense_variant | 3/3 | ENST00000381032.6 | NP_001001888.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCX3B | ENST00000381032.6 | c.304G>A | p.Asp102Asn | missense_variant | 3/3 | 5 | NM_001001888.4 | ENSP00000370420.1 |
Frequencies
GnomAD3 genomes AF: 0.000161 AC: 14AN: 87034Hom.: 0 Cov.: 13 AF XY: 0.00 AC XY: 0AN XY: 16060
GnomAD3 genomes
AF:
AC:
14
AN:
87034
Hom.:
Cov.:
13
AF XY:
AC XY:
0
AN XY:
16060
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000222 AC: 2AN: 90052Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 23924
GnomAD3 exomes
AF:
AC:
2
AN:
90052
Hom.:
AF XY:
AC XY:
0
AN XY:
23924
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000290 AC: 29AN: 998871Hom.: 0 Cov.: 29 AF XY: 0.00000980 AC XY: 3AN XY: 306027
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
29
AN:
998871
Hom.:
Cov.:
29
AF XY:
AC XY:
3
AN XY:
306027
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000161 AC: 14AN: 87061Hom.: 0 Cov.: 13 AF XY: 0.00 AC XY: 0AN XY: 16101
GnomAD4 genome
AF:
AC:
14
AN:
87061
Hom.:
Cov.:
13
AF XY:
AC XY:
0
AN XY:
16101
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.304G>A (p.D102N) alteration is located in exon 3 (coding exon 2) of the VCX3B gene. This alteration results from a G to A substitution at nucleotide position 304, causing the aspartic acid (D) at amino acid position 102 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;D
Polyphen
0.092
.;B;.
Vest4
MutPred
Gain of glycosylation at T99 (P = 0.0858);Gain of glycosylation at T99 (P = 0.0858);Gain of glycosylation at T99 (P = 0.0858);
MVP
MPC
0.90
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at